TrialThe Lancet. Oncology2023

Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial.

Eric J Sherman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.